drugset / Trial / NCT02358304

Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma

NCT02358304

Phase 2 Completed 24 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective of this randomised clinical trial is to is to compare the frequency of recurrence between patients who received nasal spray calcitonin after curettage of Central Giant Cell Granuloma and without it.

Timeline

Start
2007-09
Primary completion
2015-02
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcitonin Protein / enzyme biologic 200 iu Intranasal